Stockreport

Arcus Biosciences, Inc.'s (NYSE:RCUS) Intrinsic Value Is Potentially 30% Above Its Share Price [Yahoo! Finance]

Arcus Biosciences, Inc.  (RCUS) 
Last arcus biosciences, inc. earnings: 3/5 04:10 pm Check Earnings Report
PDF Current share price of US$17.47 suggests Arcus Biosciences is potentially 23% undervalued Analyst price target for RCUS is US$33.13, which is 46% above our fair value [Read more]